-+ 0.00%
-+ 0.00%
-+ 0.00%

Zoetis says UK regulator approves Portela for cat osteoarthritis pain

PUBT·07/30/2026 15:20:01
Listen to the news
Zoetis says UK regulator approves Portela for cat osteoarthritis pain
  • Zoetis won UK VMD clearance in Great Britain for Portela (relfovetmab) to treat osteoarthritis pain in cats.
  • The anti-NGF monoclonal antibody is dosed once every three months, extending Zoetis’ feline OA pain portfolio beyond monthly Solensia.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zoetis Inc. published the original content used to generate this news brief on July 30, 2026, and is solely responsible for the information contained therein.